Myrcludex BPharmaceutical InformationUpdated on Jun 11, 2019 View more like this | Visit SHIRLEY, NY | Contact Cathy Miller |

Myrcludex B is an experimental drug for the treatment of hepatitis B and D. The hepatitis B virus uses its surface lipopeptide pre-S1 for docking to mature liver cells via their sodium/bile acid cotransporter (NTCP) and subsequently entering the cells. Myrcludex B is a synthetic N-acylated pre-S1 that can also dock to NTCP, blocking the virus's entry mechanism.